Acrivon Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $56k | 28k | 2.03 |
| 2024-12-31 | $166k | 28k | 6.02 |
| 2024-09-30 | $207k | 30k | 7.00 |
| 2024-06-30 | $213k | 37k | 5.80 |
| 2024-03-31 | $175k | 24k | 7.15 |
| 2023-12-31 | $122k | 25k | 4.92 |
| 2023-09-30 | $237k | 25k | 9.56 |
| 2023-06-30 | $321k | 25k | 12.96 |
| 2023-03-31 | $290k | 23k | 12.69 |